Dorothea I. H. Müller

JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function

Susanne Adam, Nils Simon, Ulrike Steffen et al. · Science Translational Medicine · 2020 · 115 citations

Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis

Jule Taubmann, Brenda Krishnacoumar, Christina Böhm et al. · Scientific Reports · 2020 · 65 citations · Full text

PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass

Dorothea I. H. Müller, Cornelia Stoll, Katrin Palumbo‐Zerr et al. · Scientific Reports · 2020 · 23 citations · Full text